A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)
A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)
Recruiting · NCT07531719 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA) | central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2026-10-02 | NCT07531719 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Air Force Specialized Hospital | Cairo | Egypt | 1 |
| Neurology Department, Ain Shams University Hospitals | Cairo | Egypt | 2 |